Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Warzocha

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Cytokines, Cellular & Molecular Therapy|July 2, 1999
Antisense strategy in hematological malignanciesK Warzocha
Leukemia & Lymphoma|January 1, 1997
Antisense strategy: biological utility and prospects in the treatment of hematological malignanciesK Warzocha, D Wotowiec
Acta Haematologica Polonica|January 1, 1992
Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in miceK Warzocha, T Robak
Leukemia & Lymphoma|June 25, 1998
The tumor necrosis factor signaling complex: choosing a path toward cell death or cell proliferationK Warzocha, G Salles
Postepy Higieny I Medycyny Doswiadczalnej|January 1, 1994
[Antitumor immunotherapy]J Z Błoński, K Warzocha
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1995
2-Chlorodeoxyadenosine (2-CdA) in the treatment of patients with relapsed chronic lymphocytic leukemiaE Krykowski, K Warzocha, T Robak
Przeglad Lekarski|January 1, 1994
[Thrombocytopenia during pregnancy]K Warzocha, T Robak, E Krykowski
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1992
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppressionT Robak, E Krykowski, K Warzocha
Acta Haematologica Polonica|January 1, 1995
Tumor necrosis factor and lymphotoxin ligand-receptor system in lymphoproliferative disordersK Warzocha, G Salles, B Coiffier
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1994
Treatment of chemotherapy-induced or idiopathic bone marrow aplasia with granulocyte colony-stimulating factor (G-CSF)T Robak, E Krykowski, K Warzocha
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Cytokines, Cellular & Molecular Therapy|July 2, 1999
Antisense strategy in hematological malignanciesK Warzocha
Leukemia & Lymphoma|January 1, 1997
Antisense strategy: biological utility and prospects in the treatment of hematological malignanciesK Warzocha, D Wotowiec
Acta Haematologica Polonica|January 1, 1992
Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in miceK Warzocha, T Robak
Leukemia & Lymphoma|June 25, 1998
The tumor necrosis factor signaling complex: choosing a path toward cell death or cell proliferationK Warzocha, G Salles
Postepy Higieny I Medycyny Doswiadczalnej|January 1, 1994
[Antitumor immunotherapy]J Z Błoński, K Warzocha
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1995
2-Chlorodeoxyadenosine (2-CdA) in the treatment of patients with relapsed chronic lymphocytic leukemiaE Krykowski, K Warzocha, T Robak
Przeglad Lekarski|January 1, 1994
[Thrombocytopenia during pregnancy]K Warzocha, T Robak, E Krykowski
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1992
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppressionT Robak, E Krykowski, K Warzocha
Acta Haematologica Polonica|January 1, 1995
Tumor necrosis factor and lymphotoxin ligand-receptor system in lymphoproliferative disordersK Warzocha, G Salles, B Coiffier
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1994
Treatment of chemotherapy-induced or idiopathic bone marrow aplasia with granulocyte colony-stimulating factor (G-CSF)T Robak, E Krykowski, K Warzocha
Pageof 4